K. Peeters

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
K. Peeters, Karin Peeters
Publication record
57 papers · 5,189 citations · H-index 30

PAPERS

Highly Frequent MAPT p.R406W Carriers with a Nonconforming FTD Phenotype in the Belgian Flemish Population (1127)
20200 citationsauthor #4
In a Large Belgian AD Cohort Loss of ABCA7 Mutations Are Associated with Alzheimer’s Disease and Cerebral Amyloid Angiopathy. (1779)
20201 citationsauthor #5
In a Large Belgian AD Cohort Loss of ABCA7 Mutations Are Associated with Alzheimer's Disease and Cerebral Amyloid Angiopathy
20201 citationsauthor #5
ABCA7 mutations are major contributors to Alzheimer’s disease in Belgian patients
20200 citationsauthor #6
ABCA7 PTC mutation carriers present with Alzheimer’s disease pathology and cerebral amyloid angiopathy
20200 citationsauthor #6
Alzheimer's disease and cerebral amyloid angiopathy were associated with ABCA7 PTC mutation carriers in a large Belgian AD cohort
20200 citationsauthor #5
MAPT p.R406W carriers present with a nonconforming FTD phenotype in the Belgian Flemish population
20200 citationsauthor #4
P.94Peripheral myelin protein 2 - a novel mutation causing Charcot-Marie-Tooth neuropathy in a Bulgarian family
20190 citationsauthor #5
Loss of DPP6 in neurodegenerative dementia: a genetic player in the dysfunction of neuronal excitability
201945 citationsauthor #16
Rare nonsynonymous variants in SORT1 are associated with increased risk for frontotemporal dementia.
201830 citationsauthor #36
Clinical variability and onset age modifiers in an extended Belgian GRN founder family.
201825 citationsauthor #10
Clinical Evidence of Disease Anticipation in Families Segregating a C9orf72 Repeat Expansion
201762 citationsauthor #16
Clinical Features of TBK1 Carriers and Comparison with C9orf72, GRN and Nonmutation Carriers in a Belgian Patient Cohort (S21.007)
20161 citationsauthor #13
Mutations in glucocerebrosidase are a major genetic risk factor for Parkinson's disease and increase susceptibility to dementia in a Flanders-Belgian cohort.
201630 citationsauthor #5
Phenotypic characteristics of Alzheimer patients carrying an ABCA7 mutation
201630 citationsauthor #11
Clinical Evidence for Disease Anticipation in Families Segregating a C9orf72 Repeat Expansion (S21.006)
20160 citationsauthor #14
Mutations in ABCA7 in a Belgian cohort of Alzheimer's disease patients: a targeted resequencing study.
2015146 citationsauthor #8
P4‐193: Effect of TREM2 and PLD3 in an Alzheimer's disease family history cohort: The wisconsin registry for Alzheimer's prevention (WRAP)
20150 citationsauthor #8
Clinical features of TBK1 carriers compared with C9orf72, GRN and non-mutation carriers in a Belgian cohort
201593 citationsauthor #13
Loss of TBK1 is a frequent cause of frontotemporal dementia in a Belgian cohort
2015162 citationsauthor #13
Investigating the role of rare heterozygous TREM2 variants in Alzheimer's disease and frontotemporal dementia.
2014181 citationsauthor #13
Rare mutations in SQSTM1 modify susceptibility to frontotemporal lobar degeneration
2014113 citationsauthor #17
Oral Sessions: O1-04: Genetics: Next Generation Sequencing in Dementia P135 O1-04-02 EXOME-SEQUENCING INLATE-ONSETFAMILIES IDENTIFIED ADDITIONAL CANDIDATES GENES FOR ALZHEIMER’S DISEASE
20140 citationsauthor #33
C9orf72 G4C2 repeat expansions in Alzheimer's disease and mild cognitive impairment.
201357 citationsauthor #12
Distinct clinical characteristics of C9orf72 expansion carriers compared with GRN, MAPT, and nonmutation carriers in a Flanders-Belgian FTLD cohort.
201393 citationsauthor #19
72 G 4 C 2 repeat expansions in Alzheimer ’ s disease and mild cognitive impairment
20130 citationsauthor #12
Ataxin-2 polyQ expansions in FTLD-ALS spectrum disorders in Flanders-Belgian cohorts.
201246 citationsauthor #8
Contribution of VPS35 genetic variability to LBD in the Flanders-Belgian population.
201222 citationsauthor #8
Both common variations and rare non-synonymous substitutions and small insertion/deletions in CLU are associated with increased Alzheimer risk
201288 citationsauthor #12
DLB and PDD: a role for mutations in dementia and Parkinson disease genes?
201281 citationsauthor #7
Both common variations and rare non-synonymous substitutions and small insertion/deletions in CLU are associated with increased Alzheimer risk
20121 citationsauthor #12
A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study.
2012653 citationsauthor #29
Guanosine triphosphate cyclohydrolase 1 promoter deletion causes dopa‐responsive dystonia
201213 citationsauthor #10
TMEM106B is associated with frontotemporal lobar degeneration in a clinically diagnosed patient cohort
2011131 citationsauthor #12
GIGYF2 has no major role in Parkinson genetic etiology in a Belgian population.
201124 citationsauthor #7
Identification of 2 Loci at chromosomes 9 and 14 in a multiplex family with frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
201062 citationsauthor #5
Comprehensive Genetic and Mutation Analysis of Familial Dementia with Lewy Bodies Linked to 2q35-q36
201017 citationsauthor #5
Contribution of TARDBP to Alzheimer's Disease Genetic Etiology
201023 citationsauthor #9
Serum biomarker for progranulin‐associated frontotemporal lobar degeneration
2009204 citationsauthor #7
Founder mutation p.R1441C in the leucine-rich repeat kinase 2 gene in Belgian Parkinson's disease patients
200858 citationsauthor #8
Genetic variability in the mitochondrial serine protease HTRA2 contributes to risk for Parkinson disease
2008117 citationsauthor #8
CHMP2B C-truncating mutations in frontotemporal lobar degeneration are associated with an aberrant endosomal phenotype in vitro.
2008164 citationsauthor #8
Progranulin locus deletion in frontotemporal dementia
2008102 citationsauthor #8
Progranulin locus deletion in frontotemporal dementia
2008102 citationsauthor #7
P3‐208: Genetic variation in PCDH11X associates with Alzheimer's disease in a two‐stage GWAS study
20080 citationsauthor #10
A novel locus for dementia with Lewy bodies: a clinically and genetically heterogeneous disorder.
200758 citationsauthor #8
Mutations other than null mutations producing a pathogenic loss of progranulin in frontotemporal dementia
2007123 citationsauthor #18
Genetic contribution of PGRN, MAPT, VCP, and CHMP2B to the etiology of frontotemporal dementia
20070 citationsauthor #10
Alzheimer and Parkinson diagnoses in progranulin null mutation carriers in an extended founder family.
2007152 citationsauthor #17
Tetrasulphonated phthalocyanine thin films deposited on gold electrodes: a study using voltammetry and synchrotron micro X-ray fluorescence
20073 citationsauthor #1
P3–158: A novel locus for autosomal dominant dementia with Lewy bodies on chromosome 2Q35–36
20060 citationsauthor #5
A Belgian ancestral haplotype harbours a highly prevalent mutation for 17q21-linked tau-negative FTLD.
200686 citationsauthor #10
Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21
20061,481 citationsauthor #12
A novel presenilin 1 mutation associated with Pick's disease but not β‐amyloid plaques
2004220 citationsauthor #8
O3-05-01 A novel presenilin 1 mutation (gly183val) is associated with pick's disease in the absence of β-amyloid plaques
20042 citationsauthor #6
Tau (MAPT) mutation Arg406Trp presenting clinically with Alzheimer disease does not share a common founder in Western Europe
200373 citationsauthor #3
Familial dementia caused by MAPT R406W clinically resembles Alzheimer's disease
20020 citationsauthor #3

TIMELINE

2002 0 citations

2003 73 citations

2004 222 citations

2006 1,567 citations

2007 336 citations

2008 441 citations

2009 204 citations

2010 102 citations

2011 155 citations

2012 904 citations

2013 150 citations

2014 294 citations

2015 401 citations

2016 61 citations

2017 62 citations

2018 55 citations

2019 45 citations

2020 2 citations

COAUTHOR MAP

CONCEPT FOOTPRINT